Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Up-and-Coming Flying Car Stocks to Put on Your Must-Buy List

While the concept of flying car stocks to buy carries tremendous risks, the burgeoning industry also opens myriad possibilities.

7 Cryptos to Watch as the Blockchain Goes Flat

With investors digesting the latest (and not particularly encouraging) macroeconomic news, cryptos face a significant challenge ahead.

Steady Eddies: 7 Unshakeable Stocks for Any Type of Market

With economic circumstances treading in uncertain waters, investors may want the confidence of safe stocks to buy.

Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now

While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator.

3 Very Oversold Quantum Computing Stocks to Buy Right Now

While an incredibly risky idea, targeting oversold quantum stocks to buy may lead to significant gains based on underlying relevancies.

7 Reliable Retirement Stocks to Secure a Golden Future

It’s never too early to start thinking about retirement stocks to buy and these compelling ideas could be relevant for the long haul.

Late-Summer Steals: 7 Stocks to Buy Before Fall

With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now.

Why Is Novocure (NVCR) Stock Down 30% Today?

Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns.

Jabil (JBL) Stock Jumps 9% on BYD Deal

With BYD announcing a buyout of Jabil’s mobile electronics manufacturing business, the win-win deal bolstered JBL stock in particular.

3 Tantalizing Stocks to Buy for Under $10

While investors should stick with the predictable ideas, those that want robust returns should target these stocks under $10 to buy.